Novartis Pharmaceutical Corp. has interrupted an integrated advertising campaign for Lamisil, an anti-toenail fungus drug, after the U.S. Food and Drug Administration sent the Swiss firm a letter of ...
NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended Novartis Consumer Health to modify advertising claims for its Lamisil AT Gel Advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results